Great Basin Scientific begins clinical trial for Shiga toxin-producing E. coli diagnostic test

Download PDF Copy

Feb 13 2015

NewsGuard 100/100 Score

Great Basin Scientific, Inc. (NASDAQ: GBSN), today announced it has initiated a clinical trial for its Shiga toxin-producing E. coli (STEC) diagnostic test. The Great Basin STEC diagnostic test will also detect serotype E. coli O157:H7.

This is the third clinical trial the Company has initiated since July 2014. In December of 2014, the Company initiated a clinical trial for its Staph ID/R (identification/resistance) blood sepsis diagnostic test. In 2012 the Company launched its FDA-cleared Toxigenic C. diff diagnostic test.

SOURCE Great Basin Scientific, Inc.

Posted in: Device / Technology News

Tags: Blood, C. Diff, Clinical Trial, Diagnostic, Diagnostics, E. coli, Infectious Diseases, Pathogen, Sepsis, Toxin

Comments (0)

Download PDF Copy

Suggested Reading

More than 100,000 young people in the US live with inflammatory bowel disease

More than 100,000 young people in the US live with inflammatory bowel disease

Incorrect arm positioning inflates blood pressure readings, risking misdiagnosis

Incorrect arm positioning inflates blood pressure readings, risking misdiagnosis

Vitamin K2 reduces the frequency, intensity, and duration of nighttime leg cramps

Vitamin K2 reduces the frequency, intensity, and duration of nighttime leg cramps

Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients

Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients

Cognitive behavioral therapy shows promise for prolonged grief disorder

Cognitive behavioral therapy shows promise for prolonged grief disorder

Diagnostic performance of GPT-4 in analyzing radiology findings from brain tumors

Diagnostic performance of GPT-4 in analyzing radiology findings from brain tumors

E. coli genomic analysis uncovers antibiotic resistance mechanisms in dogs

E. coli genomic analysis uncovers antibiotic resistance mechanisms in dogs

Study uncovers how certain E. coli bacteria in the gut promote colon cancer

Study uncovers how certain E. coli bacteria in the gut promote colon cancer

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Parkinson's disease drug disrupts the gut microbiome by inducing iron deficiency